1. Home
  2. AIFF vs NEPH Comparison

AIFF vs NEPH Comparison

Compare AIFF & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIFF
  • NEPH
  • Stock Information
  • Founded
  • AIFF 2006
  • NEPH 1997
  • Country
  • AIFF United States
  • NEPH United States
  • Employees
  • AIFF N/A
  • NEPH N/A
  • Industry
  • AIFF
  • NEPH Medical/Dental Instruments
  • Sector
  • AIFF
  • NEPH Health Care
  • Exchange
  • AIFF NYSE
  • NEPH Nasdaq
  • Market Cap
  • AIFF 37.9M
  • NEPH 36.1M
  • IPO Year
  • AIFF N/A
  • NEPH 2004
  • Fundamental
  • Price
  • AIFF $3.03
  • NEPH $4.03
  • Analyst Decision
  • AIFF
  • NEPH Buy
  • Analyst Count
  • AIFF 0
  • NEPH 1
  • Target Price
  • AIFF N/A
  • NEPH $5.00
  • AVG Volume (30 Days)
  • AIFF 1.6M
  • NEPH 67.5K
  • Earning Date
  • AIFF 08-18-2025
  • NEPH 08-07-2025
  • Dividend Yield
  • AIFF N/A
  • NEPH N/A
  • EPS Growth
  • AIFF N/A
  • NEPH N/A
  • EPS
  • AIFF N/A
  • NEPH 0.08
  • Revenue
  • AIFF $139,000.00
  • NEPH $15,517,000.00
  • Revenue This Year
  • AIFF N/A
  • NEPH $17.06
  • Revenue Next Year
  • AIFF N/A
  • NEPH $12.20
  • P/E Ratio
  • AIFF N/A
  • NEPH $53.08
  • Revenue Growth
  • AIFF N/A
  • NEPH 10.34
  • 52 Week Low
  • AIFF $1.86
  • NEPH $1.36
  • 52 Week High
  • AIFF $17.20
  • NEPH $5.00
  • Technical
  • Relative Strength Index (RSI)
  • AIFF 55.14
  • NEPH 56.63
  • Support Level
  • AIFF $2.70
  • NEPH $3.83
  • Resistance Level
  • AIFF $3.09
  • NEPH $4.39
  • Average True Range (ATR)
  • AIFF 0.25
  • NEPH 0.47
  • MACD
  • AIFF 0.03
  • NEPH -0.07
  • Stochastic Oscillator
  • AIFF 47.74
  • NEPH 43.27

About AIFF FIREFLY NEUROSCIENCE INC

Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: